Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venture Life ( (GB:VLG) ) has issued an announcement.
Venture Life Group has repurchased 22,414 ordinary shares at a volume-weighted average price of 69.82 pence under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 5,287,475 are held in treasury, leaving 123,572,670 voting rights outstanding, a change that may affect shareholder notification thresholds under UK disclosure rules.
The buyback marginally reduces the free float and can be seen as part of the group’s capital management strategy, potentially signalling confidence in its valuation while offering incremental support to the share price. The updated voting rights figure provides clarity for investors monitoring their positions against regulatory disclosure requirements, ensuring compliance with the FCA’s transparency regime.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group is a UK-headquartered international consumer self-care company focused on the global self-care and healthy longevity market. Its portfolio spans women’s intimate healthcare brand Balance Activ, ENT care product Earol, Lift and Glucogel for energy and glucose management, and Health & Her products supporting the hormonal lifecycle, sold via pharmacies, health and beauty retailers, grocery chains and e-commerce, both directly and through international distributors.
Average Trading Volume: 320,342
Technical Sentiment Signal: Buy
Current Market Cap: £86.91M
See more insights into VLG stock on TipRanks’ Stock Analysis page.

